Zosano Pharma Corp Operating Cash Flow
Zosano Pharma Corp reported Operating Cash Flow of -$8.54 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-05-13
- Zosano Pharma Corp net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$8.54M.
- Zosano Pharma Corp net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$5.83M.
- Zosano Pharma Corp net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$6.32M.
- Zosano Pharma Corp net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$7.98M.
- Zosano Pharma Corp net cash provided by (used in) operating activities for fiscal 2021 was -$27.59M.
- Zosano Pharma Corp net cash provided by (used in) operating activities for fiscal 2020 was -$31.72M.
- Zosano Pharma Corp net cash provided by (used in) operating activities for fiscal 2019 was -$34.82M.
- Zosano Pharma Corp net cash provided by (used in) operating activities for fiscal 2018 was -$29.12M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$8.54M 10-Q · filed 2022-05-13 | -$14.37M derived: sum of 2 quarters · filed 2022-05-13 | -$20.69M derived: sum of 3 quarters · filed 2022-05-13 | -$28.67M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | -$5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$12.15M derived: sum of 2 quarters · filed 2022-03-17 | -$20.13M derived: sum of 3 quarters · filed 2022-03-17 | -$27.59M 10-K · filed 2022-03-17 |
| 2021-09-30 | -$6.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$14.30M derived: sum of 2 quarters · filed 2021-11-10 | -$21.76M 10-Q · filed 2021-11-10 | -$28.04M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | -$7.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$15.44M 10-Q · filed 2021-08-10 | -$21.73M derived: sum of 3 quarters · filed 2022-05-13 | -$30.72M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | -$7.46M 10-Q · filed 2022-05-13 | -$13.74M derived: sum of 2 quarters · filed 2022-05-13 | -$22.73M derived: sum of 3 quarters · filed 2022-05-13 | -$30.73M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$15.28M derived: sum of 2 quarters · filed 2022-03-17 | -$23.27M derived: sum of 3 quarters · filed 2022-03-17 | -$31.72M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$8.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$16.99M derived: sum of 2 quarters · filed 2021-11-10 | -$25.44M 10-Q · filed 2021-11-10 | -$32.90M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$16.44M 10-Q · filed 2021-08-10 | -$23.91M derived: sum of 3 quarters · filed 2021-08-10 | -$32.65M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$8.44M 10-Q · filed 2021-05-12 | -$15.91M derived: sum of 2 quarters · filed 2021-05-12 | -$24.65M derived: sum of 3 quarters · filed 2021-05-12 | -$35.79M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$16.20M derived: sum of 2 quarters · filed 2021-03-11 | -$27.35M derived: sum of 3 quarters · filed 2021-03-11 | -$34.82M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$8.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$19.88M derived: sum of 2 quarters · filed 2020-11-13 | -$27.35M 10-Q · filed 2020-11-13 | -$34.10M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$11.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$18.61M 10-Q · filed 2020-08-06 | -$25.37M derived: sum of 3 quarters · filed 2020-08-06 | -$33.34M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$7.47M 10-Q · filed 2020-05-14 | -$14.22M derived: sum of 2 quarters · filed 2020-05-14 | -$22.20M derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$14.73M derived: sum of 2 quarters · filed 2020-03-13 | -$29.12M 10-K · filed 2020-03-13 | |
| 2018-09-30 | -$7.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$22.37M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | -$14.39M 10-Q · filed 2018-08-09 | |||
| 2017-09-30 | -$6.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-15 | -$20.95M 10-Q · filed 2018-11-15 | ||
| 2017-06-30 | -$14.13M 10-Q · filed 2018-08-09 |